Delta-8-tetrahydrocannabinol, commonly called delta-8-THC or just “delta-8,” is a psychoactive cannabinoid that acts on the same brain receptors as the more familiar delta-9-THC found in marijuana, but with roughly half the potency per milligram. It has exploded onto the consumer market in the United States since around 2020, largely because of a legal gray area that allows hemp-derived products to be sold in states where marijuana remains illegal. The story of delta-8 is less about the molecule itself, which has been known to researchers for decades, and more about what happens when a loosely regulated industry mass-produces a psychoactive substance with little oversight over purity, labeling, or who ends up consuming it.
How Delta-8 Differs From Regular THC
Delta-8-THC and delta-9-THC are nearly identical in chemical structure. The only difference is the placement of one double bond in the carbon ring: at the eighth position instead of the ninth. That small shift matters because it changes how tightly the molecule binds to the CB1 receptor in the brain, the receptor responsible for the “high” associated with cannabis. Delta-8 is a partial agonist at this receptor, meaning it activates it but less strongly than delta-9-THC does. The reduced binding affinity is the main reason delta-8 produces a milder intoxication, though other factors like differences in how the body breaks it down may also play a role.1PubMed. Review of delta-8-tetrahydrocannabinol (Δ8-THC): Comparative pharmacology with Δ9-THC
Delta-8 also has a practical advantage for manufacturers: it is more chemically stable than delta-9-THC, meaning it degrades more slowly when exposed to heat, light, and oxygen.2PubMed Central. Chemistry and Pharmacology of Delta-8-Tetrahydrocannabinol This stability makes it easier to store and ship, which partly explains why it became an attractive commercial product.
Where Delta-8 Products Actually Come From
Delta-8-THC does occur naturally in the cannabis plant, but only in trace amounts far too small to extract commercially. Virtually all delta-8 on store shelves is synthesized in a laboratory by chemically converting cannabidiol (CBD) extracted from hemp. The process uses acid catalysts to rearrange CBD’s molecular structure into delta-8-THC through a reaction called cyclization. Hemp-derived CBD became cheap and abundant after the 2018 U.S. Farm Bill legalized industrial hemp, and producers sitting on surplus CBD quickly found that converting it to delta-8 was more profitable than selling CBD itself.3PubMed Central. Chemistry and Pharmacology of Delta-8-Tetrahydrocannabinol
The conversion chemistry is well understood, but executing it cleanly is another matter. Because delta-8 products are manufactured outside any pharmaceutical or food-safety framework, the quality of the starting CBD and the precision of the synthesis vary wildly. Low-quality CBD feedstock introduces impurities at the outset, and the cyclization reaction itself produces unwanted byproducts that remain in the final product if manufacturers skip rigorous purification steps.
The Impurity Problem
Independent laboratory analyses of commercial delta-8 products have painted a troubling picture. One study using mass spectrometry identified at least ten distinct impurities in delta-8 samples, including cannabinoid analogs not naturally found in cannabis, compounds that appear to originate from side reactions during synthesis, and at least one contaminant containing a nitrogen-based functional group whose origin could not be explained by any published conversion method.4PubMed Central. Delta-8 Tetrahydrocannabinol Product Impurities Some of these unknowns have never been tested for safety in humans.
A separate analysis of 27 delta-8 vaporizer products from ten different brands found that none had accurate labeling for delta-8-THC content. All of the products contained reaction byproducts, including olivetol, various THC isomers, and a previously undescribed cannabinoid the researchers named iso-tetrahydrocannabifuran. Eleven products also contained unlabeled cutting agents, and heavy metals were detected across the sample set.5Chemical Research in Toxicology. Novel Δ8-Tetrahydrocannabinol Vaporizers Contain Unlabeled Adulterants, Unintended Byproducts of Chemical Synthesis, and Heavy Metals When every single product tested in a study fails its own label claim, the labeling problem is not a matter of occasional sloppiness; it reflects an industry operating without meaningful quality control.
A broader labeling study found only a weak correlation between the delta-8-THC content advertised on product packaging and what was actually inside.6PubMed Central. Commercial Delta-8 THC Products: an Analysis of Content and Labeling For consumers, this means the dose printed on a gummy or a vape cartridge is essentially a guess.
What the High Feels Like Compared to Delta-9
People who use delta-8 consistently describe it as a less intense version of a marijuana high. A large crowdsourced survey found that users rated delta-8 lower than delta-9-THC on measures of overall drug effect, anxiety, paranoia, memory problems, and feeling sick.7PubMed. A crowdsourcing survey study on the subjective effects of delta-8-tetrahydrocannabinol relative to delta-9-tetrahydrocannabinol and cannabidiol This “lighter” profile is one of the main reasons people seek it out, particularly those who find regular THC too anxiety-provoking.
A controlled clinical trial comparing oral doses of both compounds in healthy adults confirmed the self-reports. At equal doses of 20 milligrams, delta-8 produced significantly less cognitive impairment, fewer negative subjective effects, and a smaller increase in heart rate than delta-9. However, when researchers doubled the delta-8 dose to 40 milligrams, the gap disappeared: participants rated 40 mg of delta-8 as essentially equivalent to 20 mg of delta-9 across most measures, including drug liking. That last detail matters because it suggests the abuse potential of delta-8 is similar to delta-9 once users simply take more.8PubMed. A within-subject cross-over trial comparing the acute effects of oral delta-8-tetrahydrocannabinol and delta-9-tetrahydrocannabinol in healthy adults The researchers noted that delta-8’s reduced potency may partly stem from the body converting less of it into the active metabolite 11-hydroxy-THC, which is the form thought to drive much of the subjective experience after oral consumption.
Why People Use It
Among people who used cannabis in the past month, roughly one in six reported also using delta-8-THC. Vaping concentrated delta-8 formulations was the most common method. The two most frequently cited motivations were its legal status and perceived therapeutic benefits.9Addictive Behaviors. Delta-8 THC use in US adults: Sociodemographic characteristics and correlates
A separate survey of delta-8 users found that about half used it specifically to manage health conditions, most commonly anxiety or panic attacks, stress, depression, and chronic pain. Many reported substituting delta-8 for both delta-9-THC and prescription medications, rating it favorably in comparison to both.10PubMed. Consumer Experiences with Delta-8-THC: Medical Use, Pharmaceutical Substitution, and Comparisons with Delta-9-THC In another survey, large majorities of users reported experiencing relaxation, euphoria, and pain relief.11PubMed Central. Delta-8-THC: Delta-9-THC’s nicer younger sibling?
It is worth noting, though, that self-reported therapeutic benefit in uncontrolled surveys is not the same as clinical evidence of efficacy. No rigorous clinical trials have evaluated delta-8 as a treatment for any condition, so people using it for anxiety or pain are essentially running their own unblinded experiments. Research into use motives also found that people who used delta-8 primarily to cope with negative emotions were more likely to report depression, anxiety, insomnia, and problems related to their delta-8 use itself.12PubMed. Delta-8- and Delta-9-THC Use Frequency, Use Motives, and Mental Health Outcomes
The Legal Gray Area
The 2018 Farm Bill removed hemp and hemp-derived compounds from the federal Controlled Substances Act, as long as the plant material contains no more than 0.3% delta-9-THC by dry weight. Because the law specifically names delta-9-THC and not other THC isomers, some manufacturers and retailers have argued that delta-8 synthesized from legal hemp is itself legal. Critics, including the FDA and many legal scholars, have called this a purposeful misinterpretation of the statute, which was intended to legalize hemp fiber and CBD products, not to create a back door for psychoactive cannabinoids.13PubMed Central. Δ(8)-THC: Legal Status, Widespread Availability, and Safety Concerns
In the absence of clear federal action, states have taken wildly different approaches. Some have explicitly banned delta-8, some regulate it under their existing cannabis frameworks, and many have done nothing at all. The practical result is a patchwork: adults in states with unregulated delta-8 markets reported using it at roughly three times the rate of adults in states that regulated sales, and more than twice the rate of adults in states that prohibited it.14PubMed Central. U.S. State Marijuana and Delta-8-Tetrahydrocannabinol Laws and Delta-8-Tetrahydrocannabinol Use In states where recreational marijuana is already legal, fewer people bother with delta-8 in the first place, presumably because they can simply buy the real thing from a regulated dispensary.
Poison Control Reports and Risks to Children
U.S. poison control centers tracked nearly 5,000 delta-8-THC exposure reports over just two years (2021–2022), with the rate climbing about 80% from the first year to the second. About 70% of those reports came from the U.S. South, where both recreational cannabis prohibition and unregulated delta-8 markets are concentrated. In states where delta-8 was unregulated, the exposure rate was roughly eight times higher than in states that had banned it.15PubMed Central. Delta-8 Tetrahydrocannabinol Exposures Reported to US Poison Centers: Variations Among US States and Regions and Associations with Public Policy
Children are a particular concern. Delta-8 products are frequently sold as gummies, chocolates, and other edibles that look indistinguishable from ordinary candy, and they are often marketed with bright colors and cartoon-style packaging. A national poison data study comparing pediatric exposures to hemp-derived cannabinoids (predominantly delta-8) with pediatric delta-9-THC exposures found that the hemp-derived group actually had higher rates of respiratory depression and low blood pressure, required vasopressor medication more often, and had higher rates of critical care admission and overall hospitalization. No deaths were reported in either group, but the hemp-derived cannabinoid cases were consistently more medically serious.16PubMed. Pediatric Hemp-Derived Cannabinoid and Δ9-Tetrahydrocannabinol Exposures: A National Poison Data Study One plausible explanation for the greater severity is that the unregulated products children accidentally consume may contain unknown impurities or misleading dose information, leading to larger effective exposures than the label would suggest. Delta-8 products are also readily accessible online, typically cheaper than delta-9, and lack age-verification requirements in many jurisdictions.17PubMed. Delta-8 tetrahydrocannabinol: a scoping review and commentary
Delta-8 and Drug Testing
If you use delta-8 and face a drug test, you should expect to fail it. Standard urine immunoassay screens detect a class of cannabinoid metabolites, and delta-8 metabolites trigger those screens just as reliably as delta-9 metabolites do. In a case series of four pediatric patients exposed to delta-8-THC, all tested positive on an initial urine drug screen for cannabinoids. Only confirmatory testing using more precise methods revealed that the metabolite present was 11-nor-9-carboxy-delta-8-THC rather than the delta-9 metabolite; the initial screen could not tell the difference.18PubMed Central. Delta-8-Tetrahydrocannabinol Exposure and Confirmation in Four Pediatric Patients
Most workplace, military, and legal drug tests do not routinely perform confirmatory testing that distinguishes between delta-8 and delta-9. A positive result is simply a positive result, and claiming you only used “legal” delta-8 rarely changes the outcome. Some testing programs are now starting to add delta-8-specific assays, but the practice is far from universal.
Forensic and Analytical Complications
The difficulty of distinguishing delta-8 from delta-9 extends beyond workplace drug screening. Forensic toxicology laboratories have reported that delta-8-THC metabolites can appear as an interfering peak in standard confirmatory assays designed to detect delta-9, since the two metabolites share the same molecular weight and many of the same fragmentation patterns in mass spectrometry. In a Swedish lab, samples kept appearing with peaks that matched delta-9-THC’s confirmatory criteria on most measures but had a slightly different retention time, initially confusing analysts before delta-8 was identified as the source.19PubMed. Analytical and medico-legal problems linked to the presence of delta-8-tetrahydrocannabinol (delta-8-THC): Results from urine drug testing in Sweden
Postmortem toxicology faces the same challenge. As delta-8 use has grown, labs performing death-investigation testing have had to improve chromatographic methods to adequately separate THC isomers and avoid misidentifying one as the other.20PubMed. Postmortem case series of Δ(8)- and Δ(9)-tetrahydrocannabinol in blood and urine In legal proceedings, from DUI cases to child custody disputes, the inability of a standard test to tell the two apart can muddy the interpretation of toxicology results. A person’s blood could contain delta-8 metabolites from a product sold legally in their state, but the lab report might read as positive for THC without further clarification. This ambiguity is increasingly recognized as a real medico-legal problem, though solutions are still catching up.
How the Body Processes Delta-8
Once consumed, delta-8-THC follows a metabolic pathway parallel to that of delta-9. The liver’s cytochrome P450 enzyme system hydroxylates delta-8 at the 11-carbon position, producing 11-hydroxy-delta-8-THC, which is itself psychoactive. That metabolite is then further oxidized to 11-oxo-delta-8-THC.21Drug Metabolism and Disposition. Metabolic disposition of delta 8-tetrahydrocannabinol and its active metabolites, 11-hydroxy-delta 8-tetrahydrocannabinol and 11-oxo-delta 8-tetrahydrocannabinol, in mice The fact that delta-8 appears to generate less of the 11-hydroxy intermediate than delta-9 does may help explain why equal oral doses of the two compounds don’t produce equal highs, as the clinical trial data described earlier suggested.22PubMed. A within-subject cross-over trial comparing the acute effects of oral delta-8-tetrahydrocannabinol and delta-9-tetrahydrocannabinol in healthy adults
Because delta-8 and delta-9 share the same enzyme system for their breakdown, regular users of either compound can expect similar patterns of tolerance over time, and people taking medications that interact with the same liver enzymes could see altered effects. Specific drug interaction data for delta-8 is essentially nonexistent, though, since no pharmaceutical company has ever sought approval for it and no regulatory body requires manufacturers to study it.
The Unregulated Middle Ground
Delta-8’s unusual position in the market, psychoactive enough to produce a real high yet sold outside the cannabis regulatory systems that exist in legalized states, creates a scenario that satisfies almost no one from a public health standpoint. In states with legal recreational marijuana, dispensary products undergo mandatory testing for potency, pesticides, heavy metals, and microbial contamination. Delta-8 products, sold at gas stations, convenience stores, and online, undergo no comparable scrutiny unless a state has specifically chosen to regulate them. The result is that the people most likely to encounter delta-8 are those in states with the fewest consumer protections for any cannabinoid product, since those same states tend to prohibit regulated marijuana sales.23PubMed Central. Delta-8 Tetrahydrocannabinol Exposures Reported to US Poison Centers: Variations Among US States and Regions and Associations with Public Policy
Men are more likely than women to use delta-8, and people in states with sales restrictions are less likely to use it than those in unregulated states.24Addictive Behaviors. Delta-8 THC use in US adults: Sociodemographic characteristics and correlates The demographic profile skews toward younger adults who are already cannabis users and view delta-8 as a convenient, legal, and less intense alternative. Whether that convenience is worth the trade-offs in product safety remains a question each consumer is left to answer for themselves, largely without reliable information on the label to guide the decision.